special subjects
Apoaequorin
Evidence
There are no high-quality studies demonstrating that apoaequorin is effective for improving memory loss or for treating any health condition. In a randomized study called the Madison Memory Study, 218 community-dwelling adults aged 40 to 91 with self-reported memory concerns were treated with apoaequorin or a matched placebo for 90 days. The subjects participated in various cognitive tasks designed to evaluate memory and learning. Overall, initial results and numerous posthoc analyses failed to show a significant difference in groups assigned to apoaequorin or placebo ( References ). ). The Madison Memory Study was discussed in the FTC complaint ( References ). 